beigene.com (ONC) - Cash on Hand per Share

Symbol and logo of brand BeiGene Oncology (ONC)

BeiGene Ltd (ONC) is mitigating geopolitical risks through global expansion across various regions. Tracking the cash per share trend on GURU.Markets, we note that the 55.36 mark reflects the latest data. Leading global oncologists are supporting capital growth, while the implementation of robotic laboratories is accelerating drug discovery and optimizing the company's internal costs.

BeiGene Ltd. (ONC) - Cash Funds per Share from 07/04/2022 to 11/20/2026

Comprehensive metric breakdowns and analytics for BeiGene Corp (ONC)

- current price and projected stock value:
- cash and cash flow data:
Comprehensive company analysis:ONC (BeiGene Oncology)
Finished products of BeiGene Ltd.

Cash per share determines the volume of liquid reserves attributable to a single security, allowing for an assessment of financial stability and the company's ability to fund development without external borrowing. By analyzing the cash per share trend, an investor determines the margin of safety for BeiGene Ltd. (ONC) in the face of geopolitical turbulence and regulatory restrictions between the US and China.

Analysis of competing companies

Halozyme Therapeutics - Cash Money per Share|Cash per Single Share RVMD (Revolution Medicines Corp)|Cash Calculated per Single Share AAPG|Cash Funds per Share CG Oncology Therapeutics CGON|Amount of Cash per Share URGN|BCAX: Cash per Single Share|PSNL: Cash Funds per Share|Erasca (ERAS) - Cash Funds per Share|DCTH - Cash Funds Calculated per Share|YMAB (Y-mAbs Corp) - Cash per Share|Cash per Single Share Aura Biosciences (AURA)|Cash Funds per Share Candel Therapeutics Inc. (CADL)|Cash per Single Share Accuray, Inc. ARAY|Cash Funds per Share sellaslifesciences.com SLS|Amount of Cash per Share ACTU|CTOR - Cash Funds per Share|Cash Funds Calculated per Share tuhurabio.com HURA|Protara Therapeutics, Inc. (TARA) - Cash Funds per Share|FATE: Cash Calculated per Single Share|WHWK (Aadi Bioscience, Inc.) - Cash per Share|TCRX (TScan Therapeutics) - Cash Calculated per Single Share|Cash Funds per Share Champions Oncology (CSBR)|Cash Funds Calculated per Share XBiotech USA|Cash Funds per Share CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Cash on Hand per Share|RADX - Cash Funds per Share|ARTV - Cash per Share|Adlai Nortye Ltd (ANL) - Cash Funds per Share|Veru Pharma - Amount of Cash per Share|Cash Funds per Share Tempest Therapeutics Corp|Cash Funds per Single Share XLO (Xilio Therapeutics, Inc.)|Cash per Share RENB|MURA (Mural Oncology) - Amount of Cash per Share|Cash per Share KAPA (Kairos Pharma Ltd)|OKUR: Cash Funds per Single Share|GDTC: Cash per Single Share|CRIS - Cash per Share|APLM: Cash per Share|Cash on Hand per Share tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Cash per Share|Cash per Share Genprex Inc.|Cash per Share CLDI|Cash per Single Share Sunshine Biopharma, Inc. SBFM|Cash per Share XBIO (Xenetic Biosciences)|Amount of Cash per Share SLRX|PPBT - Cash Funds per Share|AONC (aoncology.com) - Cash Funds per Single Share|BGNE: Cash per Share|Checkpoint Therapeutics Inc (CKPT) - Cash per Share|ELEV (Elevation Oncology Inc.) - Cash per Share|icadmed.com (ICAD) - Cash Funds Calculated per Share|Cash per Share IKNA|NTBL (Notable Labs) - Amount of Cash per Share|Cash per Share VIRX (Viracta Therapeutics)|Cash Funds Calculated per Share MorphoSys AG (MOR)|NAYA Biosciences Corp - Cash per Share|Cash on Hand per Share ascentage.com